Researcher Profile
Lee, Yujin(이유진)
45
Personalized Genomic Medicine Research Center (유전체맞춤의료전문연구단)
Keywords Cloud
KRIBB Co-Working
Results 1-20 of 45 (Search time: 0.005 seconds).
| No. | Year | Title | Type |
|---|---|---|---|
| 45 | 2023 | 2023Research Project 바이오 빅데이터 기반 난치성 암 맞춤의약 원천기술 개발 = Bio big-data driven study for targeted therapy of currently untreatable cancers연구책임자 : 박경찬 / 사업기간 : 2023.01.01 ~ 2023.12.31 |
Research Project |
| 44 | 2022 | 2022Report 화학유전체 기법을 활용한 전통천연약물 다중 표적 발굴 및 검증 = Multi-target discovery and validation of traditional medicines by chemical genomics연구책임자 : 한동초 / 주관부처 : 과학기술정보통신부한동초; 권병목; 이유진; 최지연; 윤선; 장현진 |
Report |
| 43 | 2022 | 2022Article S-benproperine, an active stereoisomer of benproperine, suppresses cancer migration and tumor metastasis by targeting ARPC2 = 벤프로페린의 활성 입체이성질체인 S-Benproperine은 ARPC2를 표적으로 하여 암세포 이동 및 종양 전이를 억제Pharmaceuticals, vol. 15, no. 12, pp. 1462-1462Hyun Jin Jang; Yae Jin Yoon; Jiyeon Choi; Yu-Jin Lee; Sangku Lee; W Cho; W G Byun; S B Park; Dong Cho Han; Byoung-Mog Kwon |
Article |
| 42 | 2022 | 2022Research Project 전임상 후보물질 VS-501의 기전규명 및 바이오마커 발굴연구책임자 : 한동초 / 사업기간 : 2022.02.01 ~ 2022.12.31 |
Research Project |
| 41 | 2022 | 2022Research Project 바이오 빅데이터 기반 난치성 암 맞춤의약 원천기술 개발 = Bio big-data driven study for targeted therapy of currently untreatable cancers연구책임자 : 박경찬 / 사업기간 : 2022.01.01 ~ 2022.12.31 |
Research Project |
| 40 | 2022 | 2022Research Project 화학유전체 기법을 활용한 전통천연약물 다중 표적 발굴 및 검증 = Muti-target discovery and validation of traditional medicines연구책임자 : 한동초 / 사업기간 : 2022.01.01 ~ 2022.08.31 |
Research Project |
| 39 | 2021 | 2021Article Targeting HSF1 as a therapeutic strategy for multiple mechanisms of EGFR inhibitor resistance in EGFR mutant non-small-cell lung cancer = 활성 EGFR 발현 비소세포 폐암의 EGFR 표적항암제에 대한 다중 내성 치료표적으로의 HSF1Cancers, vol. 13, no. 12, pp. 2987-2987Sangah Lee; JiYae Jung; Yu-Jin Lee; Seon-Kyu Kim; Jung Ae Kim; Bo Kyung Kim; Kyung Chan Park; Byoung-Mog Kwon; Dong Cho Han |
Article |
| 38 | 2021 | 2021Article 8-Epi-xanthatin induces the apoptosis of DU145 prostate carcinoma cells through signal transducer and activator of transcription 3 inhibition and reactive oxygen species generationPhytotherapy Research, vol. 35, pp. 1508-1520Yujin Lee; Jiyeon Choi; Yae Jin Yoon; Yugyeong Sim; Hyung Won Ryu; Sei-Ryang Oh; Doo-Young Kim; Jihyun Hwang; Seung-Wook Chi; Dong Cho Han, et al. |
Article |
| 37 | 2021 | 2021Article Acacetin inhibits the growth of STAT3-activated DU145 prostate cancer cells by directly binding to signal transducer and activator of transcription 3 (STAT3)Molecules, vol. 26, no. 20, pp. 6204-6204Sun Yun; Yujin Lee; Jiyeon Choi; Byoung-Mog Kwon; Dong Cho Han |
Article |
| 36 | 2021 | 2021Research Project 신규 유전자가위 기반 유전자치료 원천기술 개발 = Development of gene therapy through a new genome editing technology연구책임자 : 고정헌 / 사업기간 : 2021.01.01 ~ 2021.12.31 |
Research Project |
| 35 | 2021 | 2021Research Project 화학유전체 기법을 활용한 전통천연약물 다중 표적 발굴 및 검증 = Muti-target discovery and validation of traditional medicines연구책임자 : 권병목 / 사업기간 : 2021.01.01 ~ 2021.12.31 |
Research Project |
| 34 | 2021 | 2021Research Project ARPC2를 표적으로 하는 항암 및 암전이 억제제 개발 = Development of ARPC2 inhibitor for Anti-tumor and -metastasis agent연구책임자 : 권병목 / 사업기간 : 2021.01.01 ~ 2021.12.31 |
Research Project |
| 33 | 2020 | 2020Article Ethacrynic acid inhibits STAT3 activity through the modulation of SHP2 and PTP1B tyrosine phosphatases in DU145 prostate carcinoma cells = 기존 약물인 Ethacrynic acid의 항암 효과 관련 표적 발굴 및 검증Biochemical Pharmacology, vol. 175, pp. 113920-113920Yu Jin Lee; Harim Song; Yae Jin Yoon; Seung Jin Park; Seon-Young Kim; Dong Cho Han; Byoung-Mog Kwon |
Article |
| 32 | 2020 | 2020Research Project 신규 유전자가위 기반 유전자치료 원천기술 개발 = Development of gene therapy through a new genome editing technology연구책임자 : 고정헌 / 사업기간 : 2020.01.01 ~ 2020.12.31 |
Research Project |
| 31 | 2020 | 2020Research Project 화학유전체 기법을 활용한 전통천연약물 다중 표적 발굴 및 검증 = Muti-target discovery and validation of traditional medicines연구책임자 : 권병목 / 사업기간 : 2020.01.01 ~ 2020.12.31 |
Research Project |
| 30 | 2020 | 2020Research Project 세포신호전달 단백질의 기능을 조절하는 선도물질 개발 = Discovery of lead molecules for modulation of cellular signalling proteins연구책임자 : 권병목 / 사업기간 : 2020.01.01 ~ 2020.05.31 |
Research Project |
| 29 | 2020 | 2020Research Project ARPC2를 표적으로 하는 항암 및 암전이 억제제 개발 = Development of ARPC2 inhibitor for Anti-tumor and -metastasis agent연구책임자 : 권병목 / 사업기간 : 2020.03.01 ~ 2020.12.31 |
Research Project |
| 28 | 2019 | 2019Article 2'-Hydroxycinnamaldehyde inhibits proliferation and induces apoptosis via signal transducer and activator of transcription 3 inactivation and reactive oxygen species generation = 2’-Hydroxycinnamaldehyde는 STAT3와 ROS의 활성 조절을 통해 항암 효과Cancer Science, vol. 110, pp. 366-378Yae Jin Yoon; Young Hwan Kim; Yu Jin Lee; Jiyeon Choi; C H Kim; Dong Cho Han; Byoung-Mog Kwon |
Article |
| 27 | 2019 | 2019Article Benproperine, an ARPC2 inhibitor, suppresses cancer cell migration and tumor metastasis = ARPC2 저해제인 벤프로페린의 암 전이 효과Biochemical Pharmacology, vol. 163, no. 1, pp. 46-59Yae Jin Yoon; Young-Min Han; Jiyeon Choi; Yu Jin Lee; Jieun Yun; Su-Kyung Lee; Chang Woo Lee; Jong Soon Kang; Seung-Wook Chi; Jeong Hee Moon, et al. |
Article |
| 26 | 2019 | 2019Article Pimozide suppresses cancer cell migration and tumor metastasis through binding to ARPC2, a subunit of the Arp2/3 complexCancer Science, vol. 110, no. 12, pp. 3788-3801Jiyeon Choi; Yu Jin Lee; Yae Jin Yoon; C H Kim; Seung Jin Park; Seon-Young Kim; N D Kim; Dong Cho Han; Byoung-Mog Kwon |
Article |